Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions

Fig. 1

Dilemma that are faced with SCLC currently. The dilemma could be categorized into several classifications: (1) Chemoresistance in SCLC, (2) SCLC heterogeneity, (3) Unclear mechanism of pathogenesis, (4) Little progress in targeted therapy, (5) Metastasis upon initial diagnosis, (6) Lack of precision treatment, (7) Limited ICI efficacy, (8) Few therapeutic targets in SCLC

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us